IBA – ACQUISITION OF OWN SHARES
21 Février 2022 - 7:11PM
IBA – ACQUISITION OF OWN SHARES
Immediate Release – February 21st, 2022
Louvain-la-Neuve, Belgium, February
21st, 2022 - In accordance with article 8:4 of
the Royal Decree of 29 April 2019 executing the Belgian Code on
Companies and Associations, Ion Beam Applications SA (“IBA”) hereby
discloses information in relation to its share buyback program
announced on December 3rd, 2021.
Under this program, IBA has requested a
financial intermediary to repurchase up to 400.000 IBA ordinary
shares on its behalf under the terms of a discretionary mandate
agreement with validity until June 30th, 2022, effective as from
December 6th, 2021, to cover the remaining portion of the company’s
obligations under a long term incentive plan granted to certain
members of its personnel in 2021.
In the framework of this share buyback program,
IBA repurchased 45.226 IBA shares on Euronext Brussels in the
period from February 14th, 2022 up to and including February 18th,
2022, as follows:
The total number of shares purchased under this
program therefore amounts to 283.557. As a result, the current
situation with respect to treasury shares (held directly by IBA SA
and indirectly through its subsidiary IBA Investments SCRL) is the
following.
About IBA
IBA (Ion Beam Applications S.A.) is a global
medical technology company focused on bringing integrated and
innovative solutions for the diagnosis and treatment of cancer. The
company is the worldwide technology leader in the field of proton
therapy, considered to be the most advanced form of radiation
therapy available today. IBA’s proton therapy solutions are
flexible and adaptable, allowing customers to choose from universal
full-scale proton therapy centers as well as compact, single room
solutions. In addition, IBA has a radiation dosimetry business and
develops particle accelerators for the medical world and industry.
Headquartered in Belgium and employing about 1,500 people
worldwide, IBA has installed systems across the world.
IBA is listed on the pan-European stock exchange
NYSE EURONEXT (IBA: Reuters IBAB.BR and Bloomberg IBAB.BB). More
information can be found at www.iba-worldwide.com
Contact person
IBA Christian Matton,Chief
Legal Officershareholderrelations@iba-group.com
- Press release EN 20220221
Ion Beam Applications (EU:IBAB)
Graphique Historique de l'Action
De Mar 2024 à Avr 2024
Ion Beam Applications (EU:IBAB)
Graphique Historique de l'Action
De Avr 2023 à Avr 2024